Valuation: CVRx, Inc.

Market Cap 24.74M 22.19M 20.28M 18.52M 34.88M 2.33B 35.98M 244M 97.49M 1.24B 92.88M 90.89M 3.92B P/E 2026 *
-0.42x
P/E 2027 * -0.47x
Enterprise Value 35.25M 31.61M 28.89M 26.37M 49.69M 3.31B 51.26M 348M 139M 1.77B 132M 129M 5.58B EV / Sales 2026 *
0.63x
EV / Sales 2027 * 1.12x
Free-Float
85.05%
Yield 2026 *
-
Yield 2027 * -
1 day-40.90%
1 week-38.39%
Current month-38.39%
1 month-47.98%
3 months-63.65%
6 months-88.13%
Current year-87.76%
1 week 0.77
Extreme 0.774099
1.6
1 month 0.77
Extreme 0.774099
1.68
Current year 0.77
Extreme 0.774099
9.84
1 year 0.77
Extreme 0.774099
10.28
3 years 0.77
Extreme 0.774099
33.14
5 years 0.77
Extreme 0.774099
33.14
10 years 0.77
Extreme 0.774099
33.14
Manager TitleAgeSince
Chief Executive Officer 60 12/02/2024
Director of Finance/CFO 54 12/10/2026
Director of Finance/CFO 43 01/10/2020
Director TitleAgeSince
Director/Board Member 61 01/10/2008
Director/Board Member 57 01/07/2020
Director/Board Member 52 01/07/2020
Date Insider Type Main position Quantity % Market Cap. Importance
13/08/26 Buy

Chief Operating Officer

26,223 0.0988%
12/08/26 Sell

Chief Operating Officer

-1,309 0.0049%
01/06/26
Treo Ventures LLC
OtherCompany 0 0% -
Change 5-day change 1-year change 3-year change Capi.($)
-40.90%-38.39%-91.05%-94.88% 24.74M
-3.23%+3.51%-13.00%+15.96% 190B
-2.90%+5.45%+10.41%+40.45% 125B
-2.75%+11.65%-8.47%+18.50% 124B
+0.96%+5.15%-37.16%+12.09% 99.31B
-1.80%+0.82%-7.52%+70.12% 63.65B
-0.78%+7.07%+19.14%-17.27% 57.71B
+0.79%+22.65%-4.57%+60.02% 53.26B
-6.98%-14.56%-11.97%+46.23% 47.03B
-2.36%+3.72%+3.86%-7.99% 36.15B
Average -5.99%+0.90%-14.03%+14.32% 79.62B
Weighted average by Cap. -2.20%+5.71%-7.49%+25.27%

Financials

2026 *2027 *
Net sales 56.4M 50.58M 46.23M 42.2M 79.51M 5.3B 82.01M 557M 222M 2.83B 212M 207M 8.93B 60.55M 54.31M 49.63M 45.31M 85.36M 5.69B 88.05M 598M 239M 3.04B 227M 222M 9.59B
Net income -53.45M -47.94M -43.81M -40M -75.35M -5.02B -77.73M -528M -211M -2.68B -201M -196M -8.46B -52.14M -46.76M -42.73M -39.01M -73.5M -4.9B -75.82M -515M -205M -2.61B -196M -191M -8.26B
Net Debt 10.5M 9.42M 8.61M 7.86M 14.81M 987M 15.27M 104M 41.38M 527M 39.42M 38.58M 1.66B 42.94M 38.51M 35.2M 32.13M 60.53M 4.04B 62.44M 424M 169M 2.15B 161M 158M 6.8B
Projected Income Statement - Annual - CVRx, Inc.
Logo CVRx, Inc.
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.
Employees
223
Date Price Change Volume
06/11/26 $0.8687 -40.90% 5,396,532
05/11/26 $1.470 -6.96% 299,478
04/11/26 $1.580 +14.49% 368,168
03/11/26 $1.380 +0.73% 305,339
02/11/26 $1.370 -2.84% 294,148
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - CVRx, Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
0.8687USD
Average target price
4.083USD
Spread / Average Target
+370.05%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - CVRx, Inc.
  1. Stock Market
  2. Stocks
  3. CVRX Stock